Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)

China · Delayed Price · Currency is CNY

26.72

-0.68 (-2.48%)

At close: Mar 19, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceutical Manufacturing	268.79M	325.02M	360.85M	276.53M	385.69M
Pharmaceutical Manufacturing Growth	-17.30%	-9.93%	30.49%	-28.30%	-
Pharmaceutical Agent	440.52M	430.29M	387.75M	361.71M	319.13M
Pharmaceutical Agent Growth	2.38%	10.97%	7.20%	13.34%	-
Medical technology services and technology transfer	10.87M	4.76M	34.20M	15.42M	4.16M
Medical technology services and technology transfer Growth	128.22%	-86.08%	121.82%	270.42%	-
Unallocated Other Operating Income	862.97K	716.24K	684.82K	-	-
Unallocated Other Operating Income Growth	20.49%	4.59%	-	-	-
Total	721.03M	760.79M	783.48M	653.65M	708.98M
Total Growth	-5.23%	-2.90%	19.86%	-7.80%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Export	264.15K	22.00K	177.37K	13.12M	26.36M
Export Growth	1100.74%	-87.60%	-98.65%	-50.24%	-
South China	281.54M	287.00M	318.37M	259.02M	321.76M
South China Growth	-1.90%	-9.85%	22.91%	-19.50%	-
East China	188.95M	175.73M	192.04M	151.54M	142.03M
East China Growth	7.52%	-8.50%	26.72%	6.70%	-
Central China	89.03M	124.67M	116.01M	101.96M	74.64M
Central China Growth	-28.59%	7.47%	13.78%	36.60%	-
North China	45.07M	52.40M	56.18M	46.25M	37.98M
North China Growth	-13.98%	-6.73%	21.47%	21.79%	-
Southwest China	45.98M	50.89M	42.99M	32.85M	37.42M
Southwest China Growth	-9.66%	18.37%	30.90%	-12.24%	-
Northwest China	37.42M	40.99M	28.40M	26.06M	39.15M
Northwest China Growth	-8.71%	44.34%	8.97%	-33.43%	-
Northeast China	32.77M	29.09M	29.31M	22.85M	29.64M
Northeast China Growth	12.68%	-0.77%	28.30%	-22.91%	-
Total	721.03M	760.79M	783.48M	653.65M	708.98M
Total Growth	-5.23%	-2.90%	19.86%	-7.80%	-

Source: S&P Global Market Intelligence.